| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |